61 related articles for article (PubMed ID: 26611602)
1. A possible therapeutic target for Lou Gehrig's disease.
Ray SS; Lansbury PT
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5701-2. PubMed ID: 15079068
[No Abstract] [Full Text] [Related]
2. Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.
Goutman SA; Feldman EL
JAMA Neurol; 2015 Jul; 72(7):743-4. PubMed ID: 25961436
[No Abstract] [Full Text] [Related]
3. Gene therapy for neurological disorders.
Choong CJ; Baba K; Mochizuki H
Expert Opin Biol Ther; 2016; 16(2):143-59. PubMed ID: 26642082
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of amyotrophic lateral sclerosis.
Zarei S; Carr K; Reiley L; Diaz K; Guerra O; Altamirano PF; Pagani W; Lodin D; Orozco G; Chinea A
Surg Neurol Int; 2015; 6():171. PubMed ID: 26629397
[TBL] [Abstract][Full Text] [Related]
5. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS.
Sun S; Sun Y; Ling SC; Ferraiuolo L; McAlonis-Downes M; Zou Y; Drenner K; Wang Y; Ditsworth D; Tokunaga S; Kopelevich A; Kaspar BK; Lagier-Tourenne C; Cleveland DW
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):E6993-7002. PubMed ID: 26621731
[TBL] [Abstract][Full Text] [Related]
6. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
[TBL] [Abstract][Full Text] [Related]
7. [Amyotrophic lateral sclerosis. Multisystem degeneration].
Hübers A; Ludolph AC; Rosenbohm A; Pinkhardt EH; Weishaupt JH; Dorst J
Nervenarzt; 2016 Feb; 87(2):179-88. PubMed ID: 26646612
[TBL] [Abstract][Full Text] [Related]
8. Early use of non invasive ventilation in patients with amyotrophic lateral sclerosis: what benefits?
Terzano C; Romani S
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4304-13. PubMed ID: 26636518
[TBL] [Abstract][Full Text] [Related]
9. No Change in Executive Performance in ALS Patients: A Longitudinal Neuropsychological Study.
Kasper E; Zydatiss K; Schuster C; Machts J; Bittner D; Kaufmann J; Benecke R; Vielhaber S; Teipel S; Prudlo J
Neurodegener Dis; 2016; 16(3-4):184-91. PubMed ID: 26613522
[TBL] [Abstract][Full Text] [Related]
10. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
Cagin U
Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy for ALS-A Perspective.
Cappella M; Ciotti C; Cohen-Tannoudji M; Biferi MG
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500113
[TBL] [Abstract][Full Text] [Related]
12. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1
Zhou QM; Zhang JJ; Li S; Chen S; Le WD
CNS Neurosci Ther; 2017 May; 23(5):375-385. PubMed ID: 28229532
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy for the Treatment of Neurological Disorders: Amyotrophic Lateral Sclerosis.
McEachin ZT; Donsante A; Boulis N
Methods Mol Biol; 2016; 1382():399-408. PubMed ID: 26611602
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for amyotrophic lateral sclerosis.
Federici T; Boulis NM
Neurobiol Dis; 2012 Nov; 48(2):236-42. PubMed ID: 21889591
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
Alisky JM; Davidson BL
Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
[TBL] [Abstract][Full Text] [Related]
16. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
17. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Tanase K; Teng Q; Krishnaney AA; Liu JK; Garrity-Moses ME; Boulis NM
J Neurosurg Spine; 2004 Jul; 1(1):128-36. PubMed ID: 15291033
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
O'Connor DM; Boulis NM
Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
